NICE 2025: Genomic Innovation at the NBIO Showcase
National Innovation & Commercialisation Expo (NICE), World Trade Centre Kuala Lumpur
Picture of Precision Diagnostics at the NICE Expo 2025
Precision Diagnostics was honoured to be invited to the National Innovation and Commercialisation Expo (NICE) 2025, an innovation platform connecting researchers, startups, corporates, investors, policymakers, and global leaders. Organised by the Ministry of Science, Technology, and Innovation (MOSTI) and implemented by MRANTI, the event catalyzed Malaysia’s innovation and biotechnology ecosystem.
I-Nation sessions explored themes such as AI, health innovation, and policy dialogues, including BioXceed 2025, which focused on bio-commercialisation, accelerators, and bio-based enterprises.
Discussions emphasised commercialisation and funding, translating research into scalable ventures with sustainable business models.
Panel topics covered global scaling, healthcare system resilience, and challenges faced by bio-based industries.
We also extend our appreciation to the Bioeconomy Corporation for the opportunity to showcase PRECISE Pharmacogenomics at the NBIO Showcase, a biotechnology and bio-based industry summit highlighting genomic-driven healthcare solutions. Our clinically validated pharmacogenomics test empowers personalised prescribing decisions through actionable genomic insights.
It remains vital for Precision Diagnostics to foster meaningful collaborations and champion the next frontier in precision healthcare. Our participation reflects a strong alignment with the goals of Malaysia’s National Biotechnology Policy 2.0, which aims to integrate precise, data-driven treatment strategies into real-world clinical practice and deliver measurable benefits to society.
As we move forward, our focus remains on translating genomic innovation into real clinical impact, empowering better healthcare for every Malaysian.
Recent Events
